Lawrence Blatt Aligos Therapeutics, Inc. (ALGS) insider trading activity
Lawrence Blatt is Chief Executive Officer of Aligos Therapeutics, Inc.. Currently has a direct ownership of 1.85 Million shares of ALGS, which is worth approximately $71.2 Million. The most recent transaction as insider was on Oct 25, 2023, when has been sold 610,277 shares (Common Stock) at a price of $0.76 per share, resulting in proceeds of $463,810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.85M
0%
3M change
0%
12M change
Total Value Held
$71.2 Million
LB
Lawrence Blatt
Chief Executive Officer
South San Francisco, CA